Widespread gene delivery to the retina using systemic administration of AAV vectors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9114161
APP PUB NO 20120141422A1
SERIAL NO

13388083

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to compositions and methods, in particular to methods based on systemic administration of scAAV, for delivering genes to cells of the retina of mammals, and in particular to photoreceptor cells, ganglion cells, glial cells, inner nuclear layer cells or cells of the retinal pigmented epithelium.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE75794 PARIS CEDEX 16
UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6)75005 PARIS
GENETHON91000 EVRY
INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)75654 PARIS CEDEX 13
ASSOCIATION INSTITUT DE MYOLOGIE75013 PARIS

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Barkats, Martine Charenton le Pont, FR 16 136

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 25, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00